U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C24H25FO5S
Molecular Weight 443.518
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CANAGLIFLOZIN F-18

SMILES

CC1=CC=C(C=C1CC2=CC=C(S2)C3=CC=C([18F])C=C3)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O

InChI

InChIKey=XTNGUQKDFGDXSJ-ILGLIWPDSA-N
InChI=1S/C24H25FO5S/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/h2-10,19,21-24,26-29H,11-12H2,1H3/t19-,21-,22+,23-,24+/m1/s1/i25-1

HIDE SMILES / InChI

Molecular Formula C24H25FO5S
Molecular Weight 443.518
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 18:42:19 GMT 2023
Edited
by admin
on Sat Dec 16 18:42:19 GMT 2023
Record UNII
XAR27Q37KR
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CANAGLIFLOZIN F-18
Common Name English
(18F)CANAGLIFLOZIN
Common Name English
D-GLUCITOL, 1,5-ANHYDRO-1-C-(3-((5-(4-(FLUORO-18F)PHENYL)-2-THIENYL)METHYL)-4-METHYLPHENYL)-
Systematic Name English
Code System Code Type Description
FDA UNII
XAR27Q37KR
Created by admin on Sat Dec 16 18:42:20 GMT 2023 , Edited by admin on Sat Dec 16 18:42:20 GMT 2023
PRIMARY
PUBCHEM
90440019
Created by admin on Sat Dec 16 18:42:20 GMT 2023 , Edited by admin on Sat Dec 16 18:42:20 GMT 2023
PRIMARY
CAS
1415906-04-5
Created by admin on Sat Dec 16 18:42:20 GMT 2023 , Edited by admin on Sat Dec 16 18:42:20 GMT 2023
PRIMARY
Related Record Type Details
NON-LABELED -> LABELED
TARGET->RADIOLIGAND
Name Property Type Amount Referenced Substance Defining Parameters References
ORAL BIOAVAILABILITY PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC AT STEADY-STATE

SINGLE INTRAVENOUS ADMINISTRATION

Biological Half-life PHARMACOKINETIC SINGLE DOSE

ORAL ADMINISTRATION

Tmax PHARMACOKINETIC ORAL ADMINISTRATION

SINGLE DOSE

Biological Half-life PHARMACOKINETIC ORAL ADMINISTRATION

SINGLE DOSE